A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation

Epigenetics and Chromatin

Volumn 3, Issue 1, 2010, Pages

  Tierling, Sascha ^a   Schuster, Matthias ^b   Tetzner, Reimo ^c   Walter, Jörn ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Woodlands Central Industrial Estate   (Singapore)

^c EPIGENOMICS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; DNA DETERMINATION; DNA EXTRACTION; DNA METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 77953813575     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/1756-8935-3-12     Document Type: Article

References (27)

1. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. SE Ozanne M Constancia, Nat Clin Pract Endocrinol Metab 2007 3 539 546 10.1038/ncpendmet0531 17581623
2. Epigenetic changes in cancer. K Gronbaek C Hother PA Jones, APMIS 2007 115 1039 1059 10.1111/j.1600-0463.2007.apm-636.xml.x 18042143
3. Epigenetic gene silencing in cancer: the DNA hypermethylome. M Esteller, Hum Mol Genet 2007 16 50 59 10.1093/hmg/ddm018 17613547
4. Cancer biomarkers: knowing the present and predicting the future. SK Chatterjee BR Zetter, Future Oncol 2005 1 37 50 10.1517/14796694.1.1.37 16555974
5. Hypermethylation pathways to colorectal cancer. Implications for prevention and detection. JG Herman, Gastroenterol Clin North Am 2002 31 945 958 10.1016/S0889-8553(02)00058-4 12489271
6. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. ML Gonzalgo G Liang CH Spruck JM Zingg WM Rideout PA Jones, Cancer Res 1997 57 594 599 9044832
7. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. M Toyota C Ho N Ahuja KW Jair Q Li M Ohe-Toyota SB Baylin JP Issa, Cancer Res 1999 59 2307 2312 10344734
8. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. PS Yan T Efferth HL Chen J Lin F Rödel L Fuzesi TH Huang, Methods 2002 27 162 169 10.1016/S1046-2023(02)00070-1 12095276
9. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. F Model N Osborn D Ahlquist R Gruetzmann B Molnar F Sipos O Galamb C Pilarsky HD Saeger Z Tulassay K Hale S Mooney J Lograsso P Adorjan R Lesche A Dessauer J Kleiber B Porstmann A Sledziewski C Lofton-Day, Mol Cancer Res 2007 5 153 163 10.1158/1541-7786.MCR- 06-0034 17314273
10. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. JG Herman JR Graff S Myohänen BD Nelkin SB Baylin, Proc Natl Acad Sci USA 1996 93 9821 9826 10.1073/pnas.93.18.9821 8790415
11. A real-time PCR assay for DNA-methylation using methylation-specific blockers. SE Cottrell J Distler NS Goodman SH Mooney A Kluth A Olek I Schwope R Tetzner H Ziebarth K Berlin, Nucleic Acids Res 2004 32 10 10.1093/nar/gnh008 14722226
12. MethyLight: a high-throughput assay to measure DNA methylation. CA Eads KD Danenberg K Kawakami LB Saltz C Blake D Shibata PV Danenberg PW Laird, Nucleic Acids Res 2000 28 32 10.1093/nar/28.8.e32 10734209
13. Sensitive detection of DNA methylation. SE Cottrell PW Laird, Ann N Y Acad Sci 2003 983 120 130 10.1111/j.1749-6632.2003.tb05967.x 12724217
14. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. G Liang KD Robertson C Talmadge J Sumegi PA Jones, Cancer Res 2000 60 4907 4912 10987305
15. Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. S Sabbioni E Miotto A Veronese E Satin L Gramantieri L Bolondi GA Calin R Gaf G Lanza G Carli E Terrazzi C Feo A Liboni S Rullini M Negrini, Mol Diagn 2003 7 201 207 10.2165/00066982-200307030-00010 15068392
16. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. R Grützmann B Molnar C Pilarsky JK Habermann PM Schlag HD Saeger S Miehlke T Stolz F Model UJ Roblick HP Bruch R Koch V Liebenberg T Devos X Song RH Day AZ Sledziewski C Lofton-Day, PLoS One 2008 3 3759 10.1371/journal.pone.0003759 19018278
17. DNA methylation biomarkers for blood-based colorectal cancer screening. C Lofton-Day F Model T Devos R Tetzner J Distler M Schuster X Song R Lesche V Liebenberg M Ebert B Molnar R Grützmann C Pilarsky A Sledziewski, Clin Chem 2007 54 414 423 10.1373/clinchem.2007.095992 18089654
18. Circulating methylated septin 9 in plasma is a biomarker for colorectal cancer. T DeVos R Tetzner F Model G Weiss M Schuster J Distler K Vaughn-Steiger R Grützmann C Pilarsky JK Habermann R Day A Sledziewski C Lofton-Day, Clin Chem 2009 55 1337 1346 10.1373/clinchem.2008.115808 19406918
19. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). ML Gonzalgo PA Jones, Nucleic Acids Res 1997 25 2529 2531 10.1093/nar/25.12.2529 9171109
20. COBRA-a sensitive and quantitative DNA methylation assay. Z Xiong PW Laird, Nucleic Acids Res 1997 25 2532 2534 10.1093/nar/25.12.2532 9171110
21. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. M Weber JJ Davies D Wittig EJ Oakeley M Haase WL Lam D Schübeler, Nat Genet 2005 37 853 862 10.1038/ng1598 16007088
22. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. M Frommer LE McDonald DS Millar CM Collis F Watt GW Grigg PL Molloy CL Paul, Proc Natl Acad Sci USA 1992 89 1827 1831 10.1073/pnas.89.5.1827 1542678
23. Studies of X chromosome DNA methylation in normal human cells. SF Wolf BR Migeon, Nature 1982 295 667 671 10.1038/295667a0 6173772
24. A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling. C Kneip B Schmidt M Fleischhacker A Seegebarth J Lewin N Flemming S Seemann T Schlegel C Witt V Liebenberg D Dietrich, Biotechniques 2009 47 737 744 10.2144/000113208 19852759
25. Comprehensive human genome amplification using multiple displacement amplification. FB Dean S Hosono L Fang X Wu AF Faruqi P Bray-Ward Z Sun Q Zong Y Du J Du M Driscoll W Song SF Kingsmore M Egholm RS Lasken, Proc Natl Acad Sci USA 2002 99 5261 5266 10.1073/pnas.082089499 11959976
26. Control of carry-over contamination of PCR-based DNA methylation quantification using bisulfite treated DNA. R Tetzner D Dietrich J Distler, Nucleic Acids Res 2007 35 4 10.1093/nar/gkl955 17135186
27. SIRPH analysis: SNuPE with IP-RP-HPLC for quantitative measurements of DNA methylation at specific CpG sites. O El-Maarri, Methods Mol Biol 2004 287 195 205 15273413